These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21545833)

  • 21. Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum.
    Usach I; Peris JE
    Int J Pharm; 2011 Oct; 419(1-2):186-91. PubMed ID: 21843608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 2004; 26(6):409-16. PubMed ID: 15349136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
    Jackson JB; Becker-Pergola G; Guay LA; Musoke P; Mracna M; Fowler MG; Mofenson LM; Mirochnick M; Mmiro F; Eshleman SH
    AIDS; 2000 Jul; 14(11):F111-5. PubMed ID: 10983633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Sutherlandia frutescens on steroidogenesis: confirming indigenous wisdom.
    Prevoo D; Smith C; Swart P; Swart AC
    Endocr Res; 2004 Nov; 30(4):745-51. PubMed ID: 15666820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The apoptosis inducing effects of Sutherlandia spp. extracts on an oesophageal cancer cell line.
    Skerman NB; Joubert AM; Cronjé MJ
    J Ethnopharmacol; 2011 Oct; 137(3):1250-60. PubMed ID: 21824511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.
    Sekar V; Lefebvre E; Mariën K; De Pauw M; Vangeneugden T; Pozniak A; Hoetelmans RM
    Br J Clin Pharmacol; 2009 Jul; 68(1):116-9. PubMed ID: 19660009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced oral bioavailability of nevirapine within micellar nanocarriers compared with Viramune(®).
    Moretton MA; Cohen L; Lepera L; Bernabeu E; Taira C; Höcht C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Oct; 122():56-65. PubMed ID: 25016545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Chokephaibulkit K; Cressey TR; Capparelli E; Sirisanthana V; Muresan P; Hongsiriwon S; Ngampiyaskul C; Limwongse C; Wittawatmongkol O; Aurpibul L; Kabat B; Toye M; Smith ME; Eksaengsri A; McIntosh K; Yogev R;
    Antivir Ther; 2011; 16(8):1287-95. PubMed ID: 22155910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiretroviral agent nevirapine: its pharmacological action and potential for clinical use].
    Takeuchi S; Osugi T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):205-11. PubMed ID: 10584233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study.
    Battegay M; Arasteh K; Plettenberg A; Bogner JR; Livrozet JM; Witt MD; Mossdorf E; Yong CL; Zhang W; Macha S; Berger F; Stern J; Robinson P; Quinson AM
    Clin Ther; 2011 Sep; 33(9):1308-20. PubMed ID: 21872931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats.
    Darweesh RS; El-Elimat T; Zayed A; Khamis TN; Babaresh WM; Arafat T; Al Sharie AH
    BMC Pharmacol Toxicol; 2020 Nov; 21(1):77. PubMed ID: 33198812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Wit FW; Lange JM; Danner SA; Foudraine NA; Kwakkelstein MO; Reiss P; Beijnen JH; Hoetelmans RM
    AIDS; 2000 May; 14(8):F77-82. PubMed ID: 10853971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Hedgehog-Signaling Driven Genes in Prostate Cancer Cells by Sutherlandia frutescens Extract.
    Lu Y; Starkey N; Lei W; Li J; Cheng J; Folk WR; Lubahn DB
    PLoS One; 2015; 10(12):e0145507. PubMed ID: 26710108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of Sutherlandia frutescens water extracts on cell numbers, morphology, cell cycle progression and cell death in a tumorigenic and a non-tumorigenic epithelial breast cell line.
    Stander A; Marais S; Stivaktas V; Vorster C; Albrecht C; Lottering ML; Joubert AM
    J Ethnopharmacol; 2009 Jul; 124(1):45-60. PubMed ID: 19527821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of combination therapy with nelfinavir plus nevirapine.
    Merry C; Barry MG; Mulcahy F; Ryan M; Tjia JF; Halifax KL; Breckenridge AM; Back DJ
    AIDS; 1998 Jul; 12(10):1163-7. PubMed ID: 9677165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation.
    Dekker SJ; Zhang Y; Vos JC; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2016 Dec; 29(12):2136-2144. PubMed ID: 27989146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines.
    Tai J; Cheung S; Chan E; Hasman D
    J Ethnopharmacol; 2004 Jul; 93(1):9-19. PubMed ID: 15182898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines.
    Müller AC; Kanfer I
    Biopharm Drug Dispos; 2011 Nov; 32(8):458-70. PubMed ID: 22024968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance.
    Mackie NE; Fidler S; Tamm N; Clarke JR; Back D; Weber JN; Taylor GP
    HIV Med; 2004 May; 5(3):180-4. PubMed ID: 15139985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
    Saitoh A; Sarles E; Capparelli E; Aweeka F; Kovacs A; Burchett SK; Wiznia A; Nachman S; Fenton T; Spector SA
    AIDS; 2007 Oct; 21(16):2191-9. PubMed ID: 18090046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.